Details for New Drug Application (NDA): 217797
✉ Email this page to a colleague
The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.
Summary for 217797
| Tradename: | DEXAMETHASONE SODIUM PHOSPHATE |
| Applicant: | Micro Labs |
| Ingredient: | dexamethasone sodium phosphate |
| Patents: | 0 |
Pharmacology for NDA: 217797
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 217797
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 217797 | ANDA | Micro Labs Limited | 42571-432 | 42571-432-79 | 25 VIAL in 1 CARTON (42571-432-79) / 1 mL in 1 VIAL (42571-432-54) |
| DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 217797 | ANDA | Armas Pharmaceuticals | 72485-118 | 72485-118-25 | 25 VIAL, SINGLE-DOSE in 1 CARTON (72485-118-25) / 1 mL in 1 VIAL, SINGLE-DOSE (72485-118-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG PHOSPHATE/ML | ||||
| Approval Date: | Mar 27, 2024 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
